Are you over 18 and want to see adult content?
More Annotations
![A complete backup of ammersee-guide.de](https://www.archivebay.com/archive/fa071262-0b13-406c-8404-c6c6583c9393.png)
A complete backup of ammersee-guide.de
Are you over 18 and want to see adult content?
![A complete backup of swiatmotocykli.pl](https://www.archivebay.com/archive/549b8ee3-d07d-49af-bc4a-0eadcf5754f7.png)
A complete backup of swiatmotocykli.pl
Are you over 18 and want to see adult content?
![A complete backup of pescaargentina.com.ar](https://www.archivebay.com/archive/5708fe01-3fb9-437e-a96f-024643f90591.png)
A complete backup of pescaargentina.com.ar
Are you over 18 and want to see adult content?
![A complete backup of wifiincomenetwork.com](https://www.archivebay.com/archive/443259da-fe50-4478-a130-df7d8fc0c258.png)
A complete backup of wifiincomenetwork.com
Are you over 18 and want to see adult content?
![A complete backup of zellige-tegels.com](https://www.archivebay.com/archive/3050b388-513d-4e2a-a2fe-c705d9ec4a45.png)
A complete backup of zellige-tegels.com
Are you over 18 and want to see adult content?
Favourite Annotations
![A complete backup of www.cna.com.tw/news/aopl/202002250148.aspx](https://www.archivebay.com/archive2/68eb18f5-a5a2-4e08-a459-38e423637e31.png)
A complete backup of www.cna.com.tw/news/aopl/202002250148.aspx
Are you over 18 and want to see adult content?
![A complete backup of www.sueddeutsche.de/panorama/notfaelle-volkmarsen-dutzende-verletzte-nach-vorfall-bei-karnevalsumzug-dpa.ur](https://www.archivebay.com/archive2/2a9480d7-ad82-4826-a825-84a99e470408.png)
A complete backup of www.sueddeutsche.de/panorama/notfaelle-volkmarsen-dutzende-verletzte-nach-vorfall-bei-karnevalsumzug-dpa.ur
Are you over 18 and want to see adult content?
![A complete backup of www.cbssports.com/nba/news/pacers-vs-raptors-odds-line-spread-2020-nba-picks-feb-23-predictions-from-advanc](https://www.archivebay.com/archive2/bdcf3662-a4c9-42e8-8ad1-b26eacbe512c.png)
A complete backup of www.cbssports.com/nba/news/pacers-vs-raptors-odds-line-spread-2020-nba-picks-feb-23-predictions-from-advanc
Are you over 18 and want to see adult content?
Text
HOME SABCS 2021
The dates will be December 8-11, 2020. To view the SABCS 2020 Financial Disclosures, please click here. 2020 SABCS mobile app now available, please click here. You will need the SABCS mobile app to complete your evaluations and to claim CME. The deadline to submit your evaluations and post survey was January 31, 2021. SAN ANTONIO BREAST CANCER SYMPOSIUM®: 2021 SABCS® "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. The driving force behind this collaboration is the SAN ANTONIO BREAST CANCER SYMPOSIUM®: 2020 SABCS® "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. The driving force behind this collaboration is theRESOURCE LIBRARY
SABCS OnDemand is a comprehensive digital library with approximately 75 hours of education from the 2019 Symposium. PDFs of slides will be available for download June 2020. Webcasts, PDFs and MP3s all conveniently available in one location. Webcasts with presenter’s THE SAN ANTONIO BREAST CANCER SYMPOSIUM®: REGISTRATION "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. The driving force behind this collaboration is the SABCS ACCEPTING NOMINATIONS FOR THE 2021 MCGUIRE AWARD Mary-Claire King, PhD of the University of Washington in Seattle was the #SABCS20 recipient. Her presentation was titled, “Inherited Breast and Ovarian Cancer and the Resolution of a Paradox.”. Nominations for the 2021 William L. McGuire Award and Lectureship must be received electronically by April 6, 5 p.m. (CST).HOME SABCS 2021
The dates will be December 8-11, 2020. To view the SABCS 2020 Financial Disclosures, please click here. 2020 SABCS mobile app now available, please click here. You will need the SABCS mobile app to complete your evaluations and to claim CME. The deadline to submit your evaluations and post survey was January 31, 2021. SAN ANTONIO BREAST CANCER SYMPOSIUM®: 2021 SABCS® "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. The driving force behind this collaboration is the SAN ANTONIO BREAST CANCER SYMPOSIUM®: 2020 SABCS® "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. The driving force behind this collaboration is theRESOURCE LIBRARY
SABCS OnDemand is a comprehensive digital library with approximately 75 hours of education from the 2019 Symposium. PDFs of slides will be available for download June 2020. Webcasts, PDFs and MP3s all conveniently available in one location. Webcasts with presenter’s THE SAN ANTONIO BREAST CANCER SYMPOSIUM®: REGISTRATION "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. The driving force behind this collaboration is the SABCS ACCEPTING NOMINATIONS FOR THE 2021 MCGUIRE AWARD Mary-Claire King, PhD of the University of Washington in Seattle was the #SABCS20 recipient. Her presentation was titled, “Inherited Breast and Ovarian Cancer and the Resolution of a Paradox.”. Nominations for the 2021 William L. McGuire Award and Lectureship must be received electronically by April 6, 5 p.m. (CST). THE SAN ANTONIO BREAST CANCER SYMPOSIUM: 2020 OVERVIEW "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. The driving force behind this collaboration is thePRESS RELEASES
The San Antonio Breast Cancer Symposium® "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium® is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. THE SAN ANTONIO BREAST CANCER SYMPOSIUM: SABCS ® HOTELS "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. The driving force behind this collaboration is the REGISTER SOON TO ATTEND #SABCS21 IN PERSON Register soon to attend #SABCS21 in person. After a year’s worth of virtual meetings, the 44 th San Antonio Breast Cancer Symposium is coming back this year as a hybrid event combining virtual and in-person programming Dec. 7-10 at the Henry B. Gonzalez Convention Center. In-person attendance will be limited because of the COVID-19virus
POSTER PRESENTATIONS The San Antonio Breast Cancer Symposium® "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium® is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. CALL FOR ABSTRACTS, CONFERENCE AND HOTEL REGISTRATION OPEN Less than 12 weeks since the end of the 41 st annual San Antonio Breast Cancer Symposium®, the “windows” have opened for abstracts, registration and hotel reservations for SABCS® 2019, Dec. 10-14 at the Henry B. Gonzalez Convention Center.. A long lead time is necessary to prepare for the leading scientific conference in the ongoing fight against breast cancer and premalignant breast 2020 SAN ANTONIO BREAST CANCER SYMPOSIUM® 2020 San Antonio Breast Cancer Symposium® Results: Between 12/2016 and 2/2020, 58 patients enrolled (triple negative breast cancer (TNBC), n=37; HR-low or negative/Her2+, n=11; or HR- NEOADJUVANT TREATMENT WITH PEMBROLIZUMAB IMPROVES Embargoed for Release: 7:30 a.m. CT, Dec. 12, 2019 To interview Peter Schmid, contact Julia Gunther at julia.gunther@aacr.org or 215-446-6896. For a photo of Schmid, click here. POSTER SESSION/DISCUSSION Poster Session/Discussion. Tumor Biology III. PS18-01. Glucocorticoid receptor expression in early-stage triple-negative breast cancer is associated with a high level of tumor immune cell infiltrates. Dolcen DN, Dreyer M, Miller A, Biernacka A, Hatogai K, Sweis R, Nanda R, Conzen SD. UTSW, Dallas, TX; The University of Chicago, Chicago, IL. LOW-DOSE TAMOXIFEN WAS SAFE AND EFFECTIVE AT REDUCING Low-Dose Tamoxifen Was Safe and Effective at Reducing Recurrence and New Breast Disease for Patients With DCIS, LCIS, and ADH Page 3 of 3 Cancer Center at Baylor College of Medicine and the American Association for Cancer Research, supports SABCS,HOME SABCS 2021
The dates will be December 8-11, 2020. To view the SABCS 2020 Financial Disclosures, please click here. 2020 SABCS mobile app now available, please click here. You will need the SABCS mobile app to complete your evaluations and to claim CME. The deadline to submit your evaluations and post survey was January 31, 2021. SAN ANTONIO BREAST CANCER SYMPOSIUM®: 2021 SABCS® "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. The driving force behind this collaboration is the SAN ANTONIO BREAST CANCER SYMPOSIUM®: 2020 SABCS® "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. The driving force behind this collaboration is theRESOURCE LIBRARY
SABCS OnDemand is a comprehensive digital library with approximately 75 hours of education from the 2019 Symposium. PDFs of slides will be available for download June 2020. Webcasts, PDFs and MP3s all conveniently available in one location. Webcasts with presenter’s THE SAN ANTONIO BREAST CANCER SYMPOSIUM®: REGISTRATION "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. The driving force behind this collaboration is the REGISTER SOON TO ATTEND #SABCS21 IN PERSON Register soon to attend #SABCS21 in person. After a year’s worth of virtual meetings, the 44 th San Antonio Breast Cancer Symposium is coming back this year as a hybrid event combining virtual and in-person programming Dec. 7-10 at the Henry B. Gonzalez Convention Center. In-person attendance will be limited because of the COVID-19virus
PARTIAL BREAST IRRADIATION MAY BE AS EFFECTIVE AS WHOLE Embargoed for Release: 7:30 a.m. CT, Dec. 12, 2019 To interview Icro Meattini, contact Julia Gunther at julia.gunther@aacr.org or 215-446-6896. For a photo of Meattini, click here. NEOADJUVANT TREATMENT WITH PEMBROLIZUMAB IMPROVES Embargoed for Release: 7:30 a.m. CT, Dec. 12, 2019 To interview Peter Schmid, contact Julia Gunther at julia.gunther@aacr.org or 215-446-6896. For a photo of Schmid, click here. BREAST CANCER PREVENTIVE EFFECTS OF ANASTROZOLE PERSIST Breast Cancer Preventive Effects of Anastrozole Persist Long After Stopping Treatment Page 2 of 3 but it is still a significant effect and larger than that seen for tamoxifen,” said Cuzick. LOW-DOSE TAMOXIFEN WAS SAFE AND EFFECTIVE AT REDUCING Low-Dose Tamoxifen Was Safe and Effective at Reducing Recurrence and New Breast Disease for Patients With DCIS, LCIS, and ADH Page 3 of 3 Cancer Center at Baylor College of Medicine and the American Association for Cancer Research, supports SABCS,HOME SABCS 2021
The dates will be December 8-11, 2020. To view the SABCS 2020 Financial Disclosures, please click here. 2020 SABCS mobile app now available, please click here. You will need the SABCS mobile app to complete your evaluations and to claim CME. The deadline to submit your evaluations and post survey was January 31, 2021. SAN ANTONIO BREAST CANCER SYMPOSIUM®: 2021 SABCS® "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. The driving force behind this collaboration is the SAN ANTONIO BREAST CANCER SYMPOSIUM®: 2020 SABCS® "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. The driving force behind this collaboration is theRESOURCE LIBRARY
SABCS OnDemand is a comprehensive digital library with approximately 75 hours of education from the 2019 Symposium. PDFs of slides will be available for download June 2020. Webcasts, PDFs and MP3s all conveniently available in one location. Webcasts with presenter’s THE SAN ANTONIO BREAST CANCER SYMPOSIUM®: REGISTRATION "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. The driving force behind this collaboration is the REGISTER SOON TO ATTEND #SABCS21 IN PERSON Register soon to attend #SABCS21 in person. After a year’s worth of virtual meetings, the 44 th San Antonio Breast Cancer Symposium is coming back this year as a hybrid event combining virtual and in-person programming Dec. 7-10 at the Henry B. Gonzalez Convention Center. In-person attendance will be limited because of the COVID-19virus
PARTIAL BREAST IRRADIATION MAY BE AS EFFECTIVE AS WHOLE Embargoed for Release: 7:30 a.m. CT, Dec. 12, 2019 To interview Icro Meattini, contact Julia Gunther at julia.gunther@aacr.org or 215-446-6896. For a photo of Meattini, click here. NEOADJUVANT TREATMENT WITH PEMBROLIZUMAB IMPROVES Embargoed for Release: 7:30 a.m. CT, Dec. 12, 2019 To interview Peter Schmid, contact Julia Gunther at julia.gunther@aacr.org or 215-446-6896. For a photo of Schmid, click here. BREAST CANCER PREVENTIVE EFFECTS OF ANASTROZOLE PERSIST Breast Cancer Preventive Effects of Anastrozole Persist Long After Stopping Treatment Page 2 of 3 but it is still a significant effect and larger than that seen for tamoxifen,” said Cuzick. LOW-DOSE TAMOXIFEN WAS SAFE AND EFFECTIVE AT REDUCING Low-Dose Tamoxifen Was Safe and Effective at Reducing Recurrence and New Breast Disease for Patients With DCIS, LCIS, and ADH Page 3 of 3 Cancer Center at Baylor College of Medicine and the American Association for Cancer Research, supports SABCS, THE SAN ANTONIO BREAST CANCER SYMPOSIUM®: REGISTRATION "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. The driving force behind this collaboration is the SCHEDULE AT A GLANCE The San Antonio Breast Cancer Symposium® "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium® is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. THE SAN ANTONIO BREAST CANCER SYMPOSIUM: 2020 OVERVIEW "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. The driving force behind this collaboration is the THE SAN ANTONIO BREAST CANCER SYMPOSIUM: SABCS ® HOTELS "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. The driving force behind this collaboration is the SABCS ACCEPTING NOMINATIONS FOR THE 2021 MCGUIRE AWARD Mary-Claire King, PhD of the University of Washington in Seattle was the #SABCS20 recipient. Her presentation was titled, “Inherited Breast and Ovarian Cancer and the Resolution of a Paradox.”. Nominations for the 2021 William L. McGuire Award and Lectureship must be received electronically by April 6, 5 p.m. (CST). REGISTER SOON TO ATTEND #SABCS21 IN PERSON Register soon to attend #SABCS21 in person. After a year’s worth of virtual meetings, the 44 th San Antonio Breast Cancer Symposium is coming back this year as a hybrid event combining virtual and in-person programming Dec. 7-10 at the Henry B. Gonzalez Convention Center. In-person attendance will be limited because of the COVID-19virus
ORAL PRESENTATIONS
The San Antonio Breast Cancer Symposium® "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium® is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. COMBINING ATEZOLIZUMAB WITH NEOADJUVANT CHEMOTHERAPY DOES Embargoed for Release: 7:30 a.m. CT, Dec. 12, 2019 To interview Luca Gianni, contact Julia Gunther at julia.gunther@aacr.org or 215-446-6896. For a photo of Gianni, click here. COMBINING ENDOCRINE THERAPY WITH A CDK4/6 INHIBITOR Embargoed for Release: 3:15 p.m. CT, Dec. 11, 2019 To interview Joaquin Gavilá, contact Julia Gunther at julia.gunther@aacr.org or 215-446-6896. For a photo of Gavilá, click here. PHASE III KATHERINE CLINICAL TRIAL CROSSED EARLY REPORTING Phase III KATHERINE Clinical Trial Crossed Early Reporting Boundary and Met its Primary Endpoint Page 2 of 3 “The large benefit was seen consistently across all of the important subgroups of patientsHOME SABCS 2021
The dates will be December 8-11, 2020. To view the SABCS 2020 Financial Disclosures, please click here. 2020 SABCS mobile app now available, please click here. You will need the SABCS mobile app to complete your evaluations and to claim CME. The deadline to submit your evaluations and post survey was January 31, 2021. SAN ANTONIO BREAST CANCER SYMPOSIUM®: 2021 SABCS® "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. The driving force behind this collaboration is the SAN ANTONIO BREAST CANCER SYMPOSIUM®: 2020 SABCS® "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. The driving force behind this collaboration is theRESOURCE LIBRARY
The San Antonio Breast Cancer Symposium® "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium® is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. THE SAN ANTONIO BREAST CANCER SYMPOSIUM®: REGISTRATION "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. The driving force behind this collaboration is the THE SAN ANTONIO BREAST CANCER SYMPOSIUM®: REGISTRATION "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. The driving force behind this collaboration is the PARTIAL BREAST IRRADIATION MAY BE AS EFFECTIVE AS WHOLE Embargoed for Release: 7:30 a.m. CT, Dec. 12, 2019 To interview Icro Meattini, contact Julia Gunther at julia.gunther@aacr.org or 215-446-6896. For a photo of Meattini, click here. COMBINING ENDOCRINE THERAPY WITH A CDK4/6 INHIBITOR Embargoed for Release: 3:15 p.m. CT, Dec. 11, 2019 To interview Joaquin Gavilá, contact Julia Gunther at julia.gunther@aacr.org or 215-446-6896. For a photo of Gavilá, click here. BREAST CANCER PREVENTIVE EFFECTS OF ANASTROZOLE PERSIST Breast Cancer Preventive Effects of Anastrozole Persist Long After Stopping Treatment Page 2 of 3 but it is still a significant effect and larger than that seen for tamoxifen,” said Cuzick. LOW-DOSE TAMOXIFEN WAS SAFE AND EFFECTIVE AT REDUCING Low-Dose Tamoxifen Was Safe and Effective at Reducing Recurrence and New Breast Disease for Patients With DCIS, LCIS, and ADH Page 3 of 3 Cancer Center at Baylor College of Medicine and the American Association for Cancer Research, supports SABCS,HOME SABCS 2021
The dates will be December 8-11, 2020. To view the SABCS 2020 Financial Disclosures, please click here. 2020 SABCS mobile app now available, please click here. You will need the SABCS mobile app to complete your evaluations and to claim CME. The deadline to submit your evaluations and post survey was January 31, 2021. SAN ANTONIO BREAST CANCER SYMPOSIUM®: 2021 SABCS® "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. The driving force behind this collaboration is the SAN ANTONIO BREAST CANCER SYMPOSIUM®: 2020 SABCS® "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. The driving force behind this collaboration is theRESOURCE LIBRARY
The San Antonio Breast Cancer Symposium® "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium® is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. THE SAN ANTONIO BREAST CANCER SYMPOSIUM®: REGISTRATION "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. The driving force behind this collaboration is the THE SAN ANTONIO BREAST CANCER SYMPOSIUM®: REGISTRATION "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. The driving force behind this collaboration is the PARTIAL BREAST IRRADIATION MAY BE AS EFFECTIVE AS WHOLE Embargoed for Release: 7:30 a.m. CT, Dec. 12, 2019 To interview Icro Meattini, contact Julia Gunther at julia.gunther@aacr.org or 215-446-6896. For a photo of Meattini, click here. COMBINING ENDOCRINE THERAPY WITH A CDK4/6 INHIBITOR Embargoed for Release: 3:15 p.m. CT, Dec. 11, 2019 To interview Joaquin Gavilá, contact Julia Gunther at julia.gunther@aacr.org or 215-446-6896. For a photo of Gavilá, click here. BREAST CANCER PREVENTIVE EFFECTS OF ANASTROZOLE PERSIST Breast Cancer Preventive Effects of Anastrozole Persist Long After Stopping Treatment Page 2 of 3 but it is still a significant effect and larger than that seen for tamoxifen,” said Cuzick. LOW-DOSE TAMOXIFEN WAS SAFE AND EFFECTIVE AT REDUCING Low-Dose Tamoxifen Was Safe and Effective at Reducing Recurrence and New Breast Disease for Patients With DCIS, LCIS, and ADH Page 3 of 3 Cancer Center at Baylor College of Medicine and the American Association for Cancer Research, supports SABCS, SCHEDULE AT A GLANCE The San Antonio Breast Cancer Symposium® "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium® is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. THE SAN ANTONIO BREAST CANCER SYMPOSIUM: 2020 OVERVIEW "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. The driving force behind this collaboration is the THE SAN ANTONIO BREAST CANCER SYMPOSIUM: SABCS ® HOTELS "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. The driving force behind this collaboration is the SABCS ACCEPTING NOMINATIONS FOR THE 2021 MCGUIRE AWARD Mary-Claire King, PhD of the University of Washington in Seattle was the #SABCS20 recipient. Her presentation was titled, “Inherited Breast and Ovarian Cancer and the Resolution of a Paradox.”. Nominations for the 2021 William L. McGuire Award and Lectureship must be received electronically by April 6, 5 p.m. (CST).ORAL PRESENTATIONS
The San Antonio Breast Cancer Symposium® "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium® is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. NEW HER2 ANTIBODY-DRUG CONJUGATE YIELDED PROMISING New HER2 Antibody-drug Conjugate Yielded Promising Clinical Responses in Breast Cancer Patients Pretreated with T-DM1 Page 3 of 4 Hospital Organization Kyushu Cancer Center, Fukuoka, Japan16Seoul National University Hospital, Seoul, Korea, Republic of17National Cancer Center Korea, Goyang, Korea, Republic of18University of California LosAngeles/Jonsson
NEOADJUVANT TREATMENT WITH PEMBROLIZUMAB IMPROVES Embargoed for Release: 7:30 a.m. CT, Dec. 12, 2019 To interview Peter Schmid, contact Julia Gunther at julia.gunther@aacr.org or 215-446-6896. For a photo of Schmid, click here. COMBINING ATEZOLIZUMAB WITH NEOADJUVANT CHEMOTHERAPY DOES Embargoed for Release: 7:30 a.m. CT, Dec. 12, 2019 To interview Luca Gianni, contact Julia Gunther at julia.gunther@aacr.org or 215-446-6896. For a photo of Gianni, click here. RESIDUAL CANCER BURDEN CAN PREDICT OUTCOMES FOR PATIENTS Residual Cancer Burden Can Predict Outcomes for Patients With Any Breast Cancer Type Page 3 of 4 Maranon, Madrid, Spain4Mayo Clinic, Rochester, MN;5MD Anderson Cancer Center, Houston, TX;6Netherlands Cancer Institute, Amsterdam, Netherlands7Netherlands Cancer Institute, ,, Amsterdam, Netherlands8Roswell Park Comprehensive Cancer Center, Buffalo, NY;9University of Cambridge, CIRCULATING TUMOR DNA MAY HELP PREDICT RECURRENCE IN Circulating Tumor DNA May Help Predict Recurrence in Patients with Early Triple-Negative Breast Cancer Page 3 of 3 TN;13Foundation Medicine, Inc., Cambridge, MA Background: A significant proportion of patients with early-stage TNBC are treated with neoadjuvant chemotherapy (NAC). Sequencing of ctDNA after surgery can be used to detect minimal residual disease and predict which patients mayHOME SABCS 2021
The dates will be December 8-11, 2020. To view the SABCS 2020 Financial Disclosures, please click here. 2020 SABCS mobile app now available, please click here. You will need the SABCS mobile app to complete your evaluations and to claim CME. The deadline to submit your evaluations and post survey was January 31, 2021. SAN ANTONIO BREAST CANCER SYMPOSIUM®: 2021 SABCS® "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. The driving force behind this collaboration is theRESOURCE LIBRARY
SABCS OnDemand is a comprehensive digital library with approximately 75 hours of education from the 2019 Symposium. PDFs of slides will be available for download June 2020. Webcasts, PDFs and MP3s all conveniently available in one location. Webcasts with presenter’s THE SAN ANTONIO BREAST CANCER SYMPOSIUM®: REGISTRATION "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. The driving force behind this collaboration is thePRESS RELEASES
The San Antonio Breast Cancer Symposium® "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium® is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. SABCS ACCEPTING NOMINATIONS FOR THE 2021 MCGUIRE AWARD Mary-Claire King, PhD of the University of Washington in Seattle was the #SABCS20 recipient. Her presentation was titled, “Inherited Breast and Ovarian Cancer and the Resolution of a Paradox.”. Nominations for the 2021 William L. McGuire Award and Lectureship must be received electronically by April 6, 5 p.m. (CST). PARTIAL BREAST IRRADIATION MAY BE AS EFFECTIVE AS WHOLE Embargoed for Release: 7:30 a.m. CT, Dec. 12, 2019 To interview Icro Meattini, contact Julia Gunther at julia.gunther@aacr.org or 215-446-6896. For a photo of Meattini, click here. BREAST CANCER PREVENTIVE EFFECTS OF ANASTROZOLE PERSIST Breast Cancer Preventive Effects of Anastrozole Persist Long After Stopping Treatment Page 2 of 3 but it is still a significant effect and larger than that seen for tamoxifen,” said Cuzick. CIRCULATING TUMOR DNA MAY HELP PREDICT RECURRENCE IN Circulating Tumor DNA May Help Predict Recurrence in Patients with Early Triple-Negative Breast Cancer Page 3 of 3 TN;13Foundation Medicine, Inc., Cambridge, MA Background: A significant proportion of patients with early-stage TNBC are treated with neoadjuvant chemotherapy (NAC). Sequencing of ctDNA after surgery can be used to detect minimal residual disease and predict which patients may ACCELERATED PARTIAL BREAST IRRADIATION, ALTHOUGH CLOSE Embargoed for Release: 7:30 a.m. CT, Dec. 6, 2018 To interview Frank Vicini, contact Julia Gunther at julia.gunther@aacr.org or 770-403-7690. For a photo of Vicini, click here.HOME SABCS 2021
The dates will be December 8-11, 2020. To view the SABCS 2020 Financial Disclosures, please click here. 2020 SABCS mobile app now available, please click here. You will need the SABCS mobile app to complete your evaluations and to claim CME. The deadline to submit your evaluations and post survey was January 31, 2021. SAN ANTONIO BREAST CANCER SYMPOSIUM®: 2021 SABCS® "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. The driving force behind this collaboration is theRESOURCE LIBRARY
SABCS OnDemand is a comprehensive digital library with approximately 75 hours of education from the 2019 Symposium. PDFs of slides will be available for download June 2020. Webcasts, PDFs and MP3s all conveniently available in one location. Webcasts with presenter’s THE SAN ANTONIO BREAST CANCER SYMPOSIUM®: REGISTRATION "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. The driving force behind this collaboration is thePRESS RELEASES
The San Antonio Breast Cancer Symposium® "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium® is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. SABCS ACCEPTING NOMINATIONS FOR THE 2021 MCGUIRE AWARD Mary-Claire King, PhD of the University of Washington in Seattle was the #SABCS20 recipient. Her presentation was titled, “Inherited Breast and Ovarian Cancer and the Resolution of a Paradox.”. Nominations for the 2021 William L. McGuire Award and Lectureship must be received electronically by April 6, 5 p.m. (CST). PARTIAL BREAST IRRADIATION MAY BE AS EFFECTIVE AS WHOLE Embargoed for Release: 7:30 a.m. CT, Dec. 12, 2019 To interview Icro Meattini, contact Julia Gunther at julia.gunther@aacr.org or 215-446-6896. For a photo of Meattini, click here. BREAST CANCER PREVENTIVE EFFECTS OF ANASTROZOLE PERSIST Breast Cancer Preventive Effects of Anastrozole Persist Long After Stopping Treatment Page 2 of 3 but it is still a significant effect and larger than that seen for tamoxifen,” said Cuzick. CIRCULATING TUMOR DNA MAY HELP PREDICT RECURRENCE IN Circulating Tumor DNA May Help Predict Recurrence in Patients with Early Triple-Negative Breast Cancer Page 3 of 3 TN;13Foundation Medicine, Inc., Cambridge, MA Background: A significant proportion of patients with early-stage TNBC are treated with neoadjuvant chemotherapy (NAC). Sequencing of ctDNA after surgery can be used to detect minimal residual disease and predict which patients may ACCELERATED PARTIAL BREAST IRRADIATION, ALTHOUGH CLOSE Embargoed for Release: 7:30 a.m. CT, Dec. 6, 2018 To interview Frank Vicini, contact Julia Gunther at julia.gunther@aacr.org or 770-403-7690. For a photo of Vicini, click here. THE SAN ANTONIO BREAST CANCER SYMPOSIUM: 2020 OVERVIEW "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. The driving force behind this collaboration is thePRESS RELEASES
The San Antonio Breast Cancer Symposium® "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium® is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine.ORAL PRESENTATIONS
The San Antonio Breast Cancer Symposium® "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium® is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. THE SAN ANTONIO BREAST CANCER SYMPOSIUM: SABCS ® HOTELS "An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer." The San Antonio Breast Cancer Symposium is presented by the Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. The driving force behind this collaboration is the POSTER SESSION/DISCUSSION Poster Session/Discussion. Tumor Biology III. PS18-01. Glucocorticoid receptor expression in early-stage triple-negative breast cancer is associated with a high level of tumor immune cell infiltrates. Dolcen DN, Dreyer M, Miller A, Biernacka A, Hatogai K, Sweis R, Nanda R, Conzen SD. UTSW, Dallas, TX; The University of Chicago, Chicago, IL. PARTIAL BREAST IRRADIATION MAY BE AS EFFECTIVE AS WHOLE Embargoed for Release: 7:30 a.m. CT, Dec. 12, 2019 To interview Icro Meattini, contact Julia Gunther at julia.gunther@aacr.org or 215-446-6896. For a photo of Meattini, click here. COMBINING ENDOCRINE THERAPY WITH A CDK4/6 INHIBITOR Embargoed for Release: 3:15 p.m. CT, Dec. 11, 2019 To interview Joaquin Gavilá, contact Julia Gunther at julia.gunther@aacr.org or 215-446-6896. For a photo of Gavilá, click here.SABCS
SABCS 2019 Galleries. 2019 SABCS Public Friday. 2019 SABCS Public Saturday. 2019 SABCS Public Thursday. 2019 SABCS Public Tuesday. 2019 SABCS Public Wednesday. CIRCULATING TUMOR DNA MAY HELP PREDICT RECURRENCE IN Circulating Tumor DNA May Help Predict Recurrence in Patients with Early Triple-Negative Breast Cancer Page 3 of 3 TN;13Foundation Medicine, Inc., Cambridge, MA Background: A significant proportion of patients with early-stage TNBC are treated with neoadjuvant chemotherapy (NAC). Sequencing of ctDNA after surgery can be used to detect minimal residual disease and predict which patients may LOW-DOSE TAMOXIFEN WAS SAFE AND EFFECTIVE AT REDUCING Low-Dose Tamoxifen Was Safe and Effective at Reducing Recurrence and New Breast Disease for Patients With DCIS, LCIS, and ADH Page 3 of 3 Cancer Center at Baylor College of Medicine and the American Association for Cancer Research, supports SABCS,* Home
* Symposium Overview* ®">+2020 SABCS®
* ®-CallforAbstracts">+Call for Abstracts * ®-CallforAbstracts-AbstractInformation">Abstract Information * ®-SABCS®Registration">+SABCS® Registration * ®-SABCS®Registration-WelcomeLetter">Welcome Letter * ®-SABCS®Registration-GroupRegistration">Group Registration * ®-SABCS®Hotels">® Hotels">+SABCS® Hotels * ®-SABCS®Hotels-HotelGroupReservations">Hotel Group Reservations * ®-SABCS®Hotels-InternationalReservations">InternationalReservations
* ®-SABCS®Hotels-ShuttleBus">Shuttle Bus * ®-SABCS®Hotels-HotelWarningAlert">Hotel Warning Alert * ®-2020SABCSOverview">2020 SABCS Overview * ®-SatelliteSymposia">Satellite Symposia * ®-SupportExhibits">+Support & Exhibits * ®-SupportExhibits-ExhibitorInformation">Exhibitor Information * ®-TravelTransportation">+Travel & Transportation*
-TravelTransportation-InformationforInternationalTravelers">Information for International Travelers * ®-PatientAdvocates">Patient Advocates* ®-Media">Media
* ®-FAQs">FAQs
* ®-2020PreliminaryProgram">2020 Preliminary Program* ®-Blogs">Blogs
* ®">Best Of SABCS®* +Resource Library
* Past Meetings Resources * Past Meetings Press Releases* Media
* Contact
* Gallery
Media | Gallery
| Contact
* Home
* Symposium Overview* ®">2020 SABCS®
* ®-CallforAbstracts">Call for Abstracts * ®-CallforAbstracts-AbstractInformation">Abstract Information * ®-SABCS®Registration">SABCS® Registration * ®-SABCS®Registration-WelcomeLetter">Welcome Letter * ®-SABCS®Registration-GroupRegistration">Group Registration * ®-SABCS®Hotels">SABCS® Hotels * ®-SABCS®Hotels-HotelGroupReservations">Hotel Group Reservations * ®-SABCS®Hotels-InternationalReservations">InternationalReservations
* ®-SABCS®Hotels-ShuttleBus">Shuttle Bus * ®-SABCS®Hotels-HotelWarningAlert">Hotel Warning Alert * ®-2020SABCSOverview">2020 SABCS Overview * ®-SatelliteSymposia">Satellite Symposia * ®-SupportExhibits">Support & Exhibits * ®-SupportExhibits-ExhibitorInformation">Exhibitor Information * ®-TravelTransportation">Travel & Transportation*
-TravelTransportation-InformationforInternationalTravelers">Information for International Travelers * ®-PatientAdvocates">Patient Advocates* ®-Media">Media
* ®-FAQs">FAQs
* ®-2020PreliminaryProgram">2020 Preliminary Program* ®-Blogs">Blogs
* ®">Best Of SABCS®* Resource Library
* Past Meetings Resources * Past Meetings Press Releases* Media
* Contact
* Gallery
*
CALL FOR ABSTRACTS
We invite abstracts of proffered papers on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease.*
REGISTRATION
Register now and pay by October 31, 2020 to receive the discountedprice
*
HOTELS
Reserve your hotel for SABCS® through our housing bureau "Orchid Events" and get 15% off registration fee. Book early to get preferred hotel! Deadline is November 18, 2020.Announcements
* UT Health continues to monitor the Coronavirus (COVID-19). As the global impact of COVID-19 grows daily, our priority is always on the health and safety of our community. In the event that the 2020 San Antonio Breast Cancer Symposium, December 8-12 is cancelled, fees will be refunded in full. * Call for Abstracts - We invite you to submit your abstract for the 2020 San Antonio Breast Cancer Symposium. Abstracts are due by July 7, 2020 at 12:00 pm Central Time US. * The deadline to submit a nomination for the SABCS McGuire Award has been extended to April 20, 2020. * Register for the 2020 San Antonio Breast Cancer Symposium now for the discounted price which ends October 31, 2020. Make your hotel reservation first through the SABCS housing bureau and receive 15% off your registration fee! * Housing is now open! Please reserve your hotel room with Orchid Events, the official SABCS housing bureau. Reservations which have been obtained through agencies other than the official SABCS housing bureau (Orchid Events) are not guaranteed*
*
*
*
<>
1234
1
2
3
4
5
6
7
SABCS 2019 GALLERY
SABCS 2019 GALLERY
SABCS 2019 GALLERY
SABCS 2019 GALLERY
SABCS 2019 GALLERY
SABCS 2019 GALLERY
SABCS 2019 GALLERY
SABCS 2019 GALLERY
1
2
3
4
5
Future Dates
44TH ANNUAL SABCS
December 7-11, 2021
45TH ANNUAL SABCS
December 6-10, 2022
46TH ANNUAL SABCS
December 5-9, 2023
* Home
* Symoposium Overview* 2020 SABCS
* Best of SABCS
* Past Meetings
* Media
* Contact
7878 Wurzbach Road
MC 8824
San Antonio, Texas 78229, USASABCS@uthscsa.edu
210.450.1550
2020 SABCS. All rights reserved.Login
Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0